FDA MedWatch - Arstasis One Access System: Class I Recall - Components May Fracture and/or Separate

[FDA MedWatch <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: FDA MedWatch - Arstasis One Access System: Class I Recall - Components May Fracture and/or Separate

Arstasis One Access System: Class I Recall - Components May Fracture and/or Separate

AUDIENCE: Cardiology, Risk Manager

ISSUE: Components of the Arstasis One Access System may fracture and/or separate during use, which may result in patient harm. The following products are affected by this recall: Models: AAD100, AAD101; Part Numbers: FG-02279, FG-03010; Lot Numbers: 09I10268, 1OC26337, 09J06281, 10C12334. These products were distributed from May 14, 2010 through October 13, 2010.

BACKGROUND: The Arstasis One Access System is used in patients undergoing diagnostic femoral artery (upper leg) catheterization procedures. It provides device access into the vascular system. This product also helps to stop the artery from bleeding when used in conjunction with manual compression.

RECOMMENDATION: Customers should work with their local Arstasis territory manager to ensure product replacement.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

• Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
• Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

Read the MedWatch safety alert, including a link to the FDA Recall Notice, at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm242811.htm

 

Tell us how we are doing:

http://survey.foreseeresults.com/survey/display?cid=d509U9xg0gZVxkMRcoMsQg==&sid=link&cpp[date]=02_09_2011_1355&cpp[type]=S

---

You are encouraged to report all serious adverse events and product quality problems to FDA MedWatch at www.fda.gov/medwatch/report.htm

Follow MedWatch on Twitter

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420